# FB101 Intervention in Women Screened to Have Vaginal Dysbiosis

> **NCT05114031** · NA · COMPLETED · sponsor: **Freya Biosciences ApS** · enrollment: 34 (actual)

## Conditions studied

- Vaginal Flora Imbalance

## Interventions

- **OTHER:** FB101
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05114031
- **Lead sponsor:** Freya Biosciences ApS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-20
- **Primary completion:** 2022-10-15
- **Final completion:** 2023-02-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05114031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05114031, "FB101 Intervention in Women Screened to Have Vaginal Dysbiosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05114031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*